<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="904">
  <stage>Registered</stage>
  <submitdate>2/10/2005</submitdate>
  <approvaldate>2/10/2005</approvaldate>
  <nctid>NCT00232219</nctid>
  <trial_identification>
    <studytitle>Use of Fish Oils to Reduce Recurrence of Atrial Fibrillation Following DC Cardioversion</studytitle>
    <scientifictitle>Use of Fish Oils to Reduce Recurrence of Atrial Fibrillation Following DC Cardioversion.</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>2003.188</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Atrial Fibrillation</healthcondition>
    <conditioncode>
      <conditioncode1>Cardiovascular </conditioncode1>
      <conditioncode2>Other cardiovascular diseases</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Treatment: drugs - Fish oil

No Intervention: Control - No fish oil exposure

Experimental: Fish oil - Patients given 6g/day of fish oil containing 1.8g/d of EPA+DHA in a 1.5:1 ratio.


Treatment: drugs: Fish oil


</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Recurrence of atrial fibrillation followed cardioversion</outcome>
      <timepoint>1 year</timepoint>
    </primaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  Patients with persistent Atrial Fibrillation on Warfarin.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>80</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>-  paroxysmal atrial fibrillation with self terminating episodes.

          -  left atrial size&gt;6.0cm

          -  myocardial infarction in the previous 6 months.

          -  contraindications to amiodarone use .

          -  cardiac surgery in the previous 3 months .

          -  an acute reversible illness contributing to the development of af

          -  a QTc interval &gt; 480ms.

          -  pregnancy</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate />
    <actualstartdate>1/01/2003</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize />
    <actualsamplesize>200</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>1/11/2013</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC</recruitmentstate>
    <hospital>Royal Melbourne hospital - Melbourne</hospital>
    <postcode>3050 - Melbourne</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Melbourne Health</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>The purpose of this study is to investigate whether fish oil supplements may be beneficial in
      preventing the recurrence of atrial fibrillation after cardioversion.

      Atrial fibrillation is a heart condition which can sometimes be successfully treated by a
      cardioversion.

      Cardioversion involves resetting the heart back to normal with the use of electric current.

      There is a tendency for the atrial fibrillation to recur , days weeks or even months after
      the cardioversion.

      Fish oil supplements may be of benefit to patients with heart problems Recent evidence
      suggests that fish oils may be beneficial to patients with rhythm disturbances.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT00232219</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Paul Sparks, MBBS, PhD. FRACP</name>
      <address>Melbourne Health</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>